Author

Yasunari Kanda

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Beyond NAMs versus animal models: Context of use as the governing framework for integrated nonclinical strategies in drug development.

New approach methodologies (NAMs) originated in chemical hazard assessment, where two forces operate together: the scale of characterizing many substances, and a long-standing ethical and legal commitment to replacing animal testing. Drug development is weighted differently. It is a translational and decision problem a...

Stefano Gaburro, B. Berridge, Nicholas W. Kelley et al. · Regulatory toxicology and ph... · 0 citations

Review Sep 2026

[Global trends in drug development using alternatives to animal testing].

This review outlines international and domestic regulatory trends in NAMs and highlights recent advances in organ-specific toxicity assessment using human-relevant models, including cardiotoxicity, hepatotoxicity, and neurotoxicity.

S. Yanagida, Hiroyuki Kawagishi, Yasunari Kanda · Nihon yakurigaku zasshi. Fol... · 0 citations